Pr Mahasti Saghatchian

Specialty

Oncologist, breast expert

Title

Head of service

Hospital

Hôpital Américain (Paris)

Latest articles

• Leveraging G-CSF prescribing in the outpatient setting: considerations beyond clinical factors-a questionnaire study. (14 mai 2024)
• Trastuzumab deruxtecan in previously treated HER2-positive metastatic or unresectable breast cancer: Real-life data from the temporary use authorization program in France. (1 mai 2024)
• Real-World Impact of Adjuvant Anti-HER2 Treatment on Characteristics and Outcomes of Women With HER2-Positive Metastatic Breast Cancer in the ESME Program. (3 oct. 2023)
• [Adapted physical activity and metastatic cancer: What needs and expectations?]. (1 déc. 2022)
• Creation of a tool to evaluate supportive care. (1 août 2022)